MedTrace Logo

Neuron Specific Enolase (NSE) as Outcome Parameter of Cooling Therapy After Survived Sudden Cardiac Death

NCT01102153 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2010-04-13

No results posted yet for this study

Summary

Sudden cardiac death remains one of the major leading causes of death. Therapeutic hypothermia is a validated standard procedure to avoid or minimize cognitive deficits after cardiac arrest. To assess the efficiency of different cooling methods and further improve these methods, the investigators collected blood samples to measure the neuron specific enolase (NSE) in patients treated with invasive cooling as compared to patients treated with non-invasive cooling.

Conditions

  • Cardiac Arrest
  • Hypothermia

Interventions

DEVICE

Coolgard

invasive cooling via femoral ICY-catheter

DEVICE

ArcticSun

non-invasive surface cooling by saline-cooled thermo-vest

Sponsors & Collaborators

  • University of Leipzig

    lead OTHER

Principal Investigators

  • Holger Thiele, Associate Professor · Study Chair

  • Undine Pittl, MD · Study Sub-Investigator

  • Alexandra Schratter, MD · Study Sub-Investigator

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01102153 on ClinicalTrials.gov